Dividend compounder review
TECH
Bio-Techne Corp · NASDAQ · US
Healthcare · Biotechnology
Score70.00/100
Confidence100.00/100
DecisionReject
RatingAcceptable, Needs Review
Quality breakdown
Dividend Reliability
20.0 / 25
Payment history, cuts, growth, and regularity.
Dividend Sustainability
20.0 / 20
Payout, free cash flow, dividend cover, and debt.
Business Quality
19.5 / 25
Scale, cash generation, growth, margins, and returns.
Valuation Discipline
10.5 / 15
Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend
0.0 / 15
Trend line, long return history, and drawdown control.
Dividend and business context
Dividend Years18
Dividend Yield0.59%
Payout Ratio45.7%
Dividend Cut 5YNo
Net Income$73.4M
Free Cash Flow$256.6M
FCF Covers DividendYes
Debt / Equity0.14
P/E77.1
Revenue Growth 5Y10.5%
Net Margin9.0%
ROE5.3%
Price vs Trend-5.3%
3Y Return-28.4%
5Y Return-49.4%
CurrencyUSD
Activity record
Recorded dividend payment for Bio-Techne Corp.
Recorded dividend payment for Bio-Techne Corp.
Recorded dividend payment for Bio-Techne Corp.
Recorded dividend payment for Bio-Techne Corp.
Recorded dividend payment for Bio-Techne Corp.
Recorded dividend payment for Bio-Techne Corp.
Recorded dividend payment for Bio-Techne Corp.
Recorded dividend payment for Bio-Techne Corp.
Recorded dividend payment for Bio-Techne Corp.
Recorded dividend payment for Bio-Techne Corp.
Recorded dividend payment for Bio-Techne Corp.
Recorded dividend payment for Bio-Techne Corp.
Payment changed from 0.07 to 0.075.